help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 70, No. 1 35-42
doi:10.1210/jcem-70-1-35
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROMIJN, J. A.
Right arrow Articles by WIERSINGA, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROMIJN, J. A.
Right arrow Articles by WIERSINGA, W. M.

Decreased Nocturnal Surge of Thyrotropin in Nonthyroidal Illness*

J. A. ROMIJN and W. M. WIERSINGA

Departments of Intensive Care (J.A.R.) and Endocrinology (W.M.W.), Academic Medical Centre, University of Amsterdam 1105 AZ Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: J. A. Romijn, M.D., Department of Intensive Care, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

To evaluate the regulation of TSH secretion in nonthyroidal illness (NTI) we studied the nocturnal TSH surge in 11 healthy controls and 26 NTI patients; none of the patients was on medication known to interfere with TSH secretion. The presence of a nocturnal TSH surge was defined as a mean nighttime TSH (the mean of 5 samples taken hourly from 0000–0400 h) significantly greater than the mean daytime TSH (the mean of 5 samples taken from 1500–1900 h).

A nocturnal TSH surge was present in 11 of 26 NTI patients and in 11 of 11 controls (P < 0.01). Both the absolute (0.3 ± 0.1 vs. 1.0 ± 0.2 mU/L; P < 0.01) and relative (11 ± 6% vs. 71 ± 12%; P < 0.001) nocturnal TSH surges were lower in NTI patients than in controls. NTI patients had lower plasma T3 (1.11 ± 0.08 vs. 1.84 ± 0.11 nmol/L; P < 0.001) and higher plasma rT3 (0.81 ± 0.24 vs. 0.23 ± 0.01 nmol/L; P < 0.001) concentrations than controls, but T4, FT4, and TSH values were similar in both groups.

No differences were found between the 15 NTI patients without nocturnal TSH surge and the 11 patients with a nocturnal TSH surge in sex distribution, age, caloric intake, or plasma T4 and T3, but hospital mortality was slightly, although not significantly, higher in those with an absent nocturnal TSH surge. An absent nocturnal TSH surge occurred in 2 of 2 patients with a low TSH (<0.4 mU/L), in 11 of 20 patients with a normal TSH (0.4–4.0 mU/L), and in 2 of 4 patients with a high TSH (>4.0 mU/L). Pituitary TSH responsiveness to TRH was similar in patients with or without a nocturnal TSH surge.

We conclude that NTI is frequently associated with a decreased nocturnal TSH surge. This phenomenon is not related to ambient plasma T4, T3, or TSH concentrations or pituitary TSH responsiveness to TRH. A decreased nocturnal TSH surge appears to be one of the features of the sick euthyroid syndrome and is probably related to hypothalamic dysregulation.

* Presented in part at the 17th Annual Meeting of the European Thyroid Association, La Grande Motte, France, September 11–16,1988.

Received .




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
H. Filipsson and G. Johannsson
GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies
Eur. J. Endocrinol., November 1, 2009; 161(S1): S85 - S95.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. Fernandez, M. Brada, L. Zabuliene, N. Karavitaki, and J. A H Wass
Radiation-induced hypopituitarism
Endocr. Relat. Cancer, September 1, 2009; 16(3): 733 - 772.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Filipsson, E. Nystrom, and G. Johannsson
Exploring the use of recombinant human TSH in the diagnosis of central hypothyroidism
Eur. J. Endocrinol., August 1, 2008; 159(2): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Rocchi, H. Kimura, S.-C. Tzou, K. Suzuki, N. R. Rose, A. Pinchera, P. W. Ladenson, and P. Caturegli
Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness
PNAS, April 3, 2007; 104(14): 6019 - 6024.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. H. Darzy and S. M. Shalet
Circadian and Stimulated Thyrotropin Secretion in Cranially Irradiated Adult Cancer Survivors
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6490 - 6497.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. Peeters, P. J. Wouters, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe
Serum 3,3',5'-Triiodothyronine (rT3) and 3,5,3'-Triiodothyronine/rT3 Are Prognostic Markers in Critically Ill Patients and Are Associated with Postmortem Tissue Deiodinase Activities
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4559 - 4565.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. S. Nylen and B. Muller
Endocrine Changes in Critical Illness
J Intensive Care Med, March 1, 2004; 19(2): 67 - 82.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Yamakita, T. Komaki, T. Takao, T. Murai, K. Hashimoto, and K. Yasuda
Usefulness of Thyrotropin (TSH)-Releasing Hormone Test and Nocturnal Surge of TSH for Diagnosis of Isolated Deficit of TSH Secretion
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1054 - 1060.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. van der Poll, E. Endert, S. M. Coyle, J. M. Agosti, and S. F. Lowry
Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R357 - R362.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Wang, J. C. Nelson, and R. B. Wilcox
Salsalate Administration--A Potential Pharmacological Model of the Sick Euthyroid Syndrome
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3095 - 3099.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Goichot, L. Weibel, F. Chapotot, C. Gronfier, F. Piquard, and G. Brandenberger
Effect of the shift of the sleep-wake cycle on three robust endocrine markers of the circadian clock
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E243 - E248.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Späth-Schwalbe, K. Hansen, F. Schmidt, H. Schrezenmeier, L. Marshall, K. Burger, H. L. Fehm, and J. Born
Acute Effects of Recombinant Human Interleukin-6 on Endocrine and Central Nervous Sleep Functions in Healthy Men
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1573 - 1579.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Fliers, S. E. F. Guldenaar, W. M. Wiersinga, and D. F. Swaab
Decreased Hypothalamic Thyrotropin-Releasing Hormone Gene Expression in Patients with Nonthyroidal Illness
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4032 - 4036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society